AMGN - AMGEN INC
329.82
-16.430 -4.982%
Share volume: 3,804,778
Last Updated: 05-01-2026
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.23%
PREVIOUS CLOSE
CHG
CHG%
$346.25
-16.43
-0.05%
View ratios
| Fiscal Date | 06-30-2024 | 09-30-2024 | 12-31-2024 | 03-31-2025 | 06-30-2025 | 09-30-2025 | 12-31-2025 | 03-31-2026 | |
|---|---|---|---|---|---|---|---|---|---|
| Fiscal Quarter | Q2 2024 | Q3 2024 | Q4 2024 | Q1 2025 | Q2 2025 | Q3 2025 | Q4 2025 | Q1 2026 | |
| Report Date | 08-06-2024 | 10-30-2024 | 02-14-2025 | 05-01-2025 | 08-05-2025 | 11-04-2025 | 02-13-2026 | 04-30-2026 | |
| Total revenue | 8.388 B | 8.503 B | 9.086 B | 8.149 B | 9.179 B | 9.557 B | 9.866 B | 8.618 B | |
| Cost of revenue | 3.236 B | 3.310 B | 3.112 B | 2.968 B | 3.011 B | 3.082 B | 2.976 B | 2.744 B | |
| Gross profit | 5.152 B | 5.193 B | 5.974 B | 5.181 B | 6.168 B | 6.475 B | 6.890 B | 5.874 B | |
| 0.80% | 15.04% | -13.27% | 19.05% | 4.98% | 6.41% | -14.75% | |||
| Operating expenses | 3.232 B | 3.075 B | 3.850 B | 4.003 B | 3.512 B | 3.949 B | 4.170 B | 3.321 B | |
| Selling general and admin | 1.785 B | 1.625 B | 2.126 B | 2.517 B | 1.768 B | 2.049 B | 2.028 B | 1.602 B | |
| Research and development | 1.447 B | 1.450 B | 1.724 B | 1.486 B | 1.744 B | 1.900 B | 2.142 B | 1.719 B | |
| Total expenses | 3.243 B | 3.146 B | 3.663 B | 4.003 B | 3.512 B | 3.949 B | 4.170 B | 3.208 B | |
| -2.99% | 16.43% | 9.28% | -12.27% | 12.44% | 5.60% | -23.07% | |||
| Operating income | 1.909 B | 2.047 B | 2.311 B | 1.178 B | 2.656 B | 2.526 B | 2.720 B | 2.666 B | |
| Ebit | 1.602 B | 3.877 B | 1.529 B | 2.696 B | 2.262 B | 4.606 B | 2.167 B | 2.741 B | |
| Pretax income | 794.000 M | 3.101 B | 782.000 M | 1.973 B | 1.568 B | 3.921 B | 1.514 B | 2.084 B | |
| 290.55% | -74.78% | 152.30% | -20.53% | 150.06% | -61.39% | 37.65% | |||
| Income tax | 48.000 M | 271.000 M | 155.000 M | 243.000 M | 136.000 M | 705.000 M | 181.000 M | 265.000 M | |
| Net income basic | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | 0.000 | |
| Net income | 746.000 M | 2.830 B | 627.000 M | 1.730 B | 1.432 B | 3.216 B | 1.333 B | 1.819 B | |
| 279.36% | -77.84% | 175.92% | -17.23% | 124.58% | -58.55% | 36.46% |